- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05082324
Evaluation of Modification in VO2 Max After Performing the "Physical Activity and Health Course (PAPS) 53" Program (EVOP-53)
Evaluation of Modification in VO2 Max After Performing the PAPS 53 Program
Physical inactivity is the leading cause of preventable death in developed countries, ahead of smoking. It is responsible for 5.3 million (9%) of the 57 million deaths worldwide in 2008 and 10% of deaths in Europe.
Encouraging regular physical activity in the general population is a public health priority.
Cardiorespiratory capacity, measured during an exercise test, expressed as maximal oxygen consumption (VO2 max) or Metabolic Equivalent Task (MET) = oxygen consumption at rest [3.5 ml/kg/min], is an excellent indicator of individual exercise capacity and is increased by regular physical activity (PA).
Any gain in cardiorespiratory capacity of 1 MET is accompanied by a 12% reduction in mortality whether the subjects are free of any cardiovascular pathology or have a chronic pathology, regardless of their age.
As physical activity is an integral part of the management of many diseases, it seems essential to evaluate specific protocols oriented towards the maintenance or development of strength or endurance, or even mixed protocols.
The PAPS 53 (Physical Activity and Health Pathway), set up in Mayenne, responds to the demand for prescription of adapted physical activity. It is a 3-month program with 2 one-hour sports sessions per week (30 minutes of endurance and 30 minutes of muscle strengthening).
The National Sport and Health Strategy 2019-2024 expert group recommends better defining the characteristics of physical activity (intensity, frequency, etc.) to determine the effect (dose-response) on different at-risk populations and according to the type of pathology.
Investigators proposed to study by comparison the VO2 max values obtained during the two exercise tests (at inclusion and after 3 months of physical activity program). The hypothesis is that, after completion of the PAPS program, the VO2 max value of a patient will be significantly increased.
The control group is represented by the patients who have not yet followed the adapted physical activity program. The intervention group is therefore composed of the same patients. The aim is to compare the same group of eligible patients, before and after having followed the "PAPS 53" protocol
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Laval, France
- CH Laval
-
Contact:
- GODET Raphaël
- Email: raphael.godet@chlaval.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult (≥ 18 years)
- Patient integrating the PAPS 53 with an indication to perform a stress test
- Person affiliated or benefiting from a social security plan
- Patient having signed an informed consent beforehand
Exclusion Criteria:
- Contraindication to the performance of the stress test
- Patient unable to understand the objectives or instructions of the study
- Poor understanding of the French language
- Pregnant, nursing or parturient woman
- Person deprived of liberty by judicial or administrative decision
- Person under forced psychiatric care
- Person admitted to a health or social institution for purposes other than research research
- Person subject to a legal protection measure
- Person unable to express his or her consent
- Person in a period of exclusion relative to another intervention research
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: adapted physical activity
|
Patient participates in an adapted physical activity program for 3 months, with 2 one-hour sports sessions per week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To assess maximal oxygen consumption (VO2 max) measured during an effort test
Time Frame: 3 month
|
Effort test
|
3 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To assess the quality of life
Time Frame: 3 month
|
Short Form-36; min value 36 and max value 149
|
3 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 49RC21_0332
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardio-Respiratory Failure
-
Hemovent GmbHMAXIS Medical, LLCActive, not recruitingRespiratory Failure | Cardiac Failure | Cardio-Respiratory FailureGermany
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingRespiratory Failure | Cardio Respiratory Arrest | Indication of Orotracheal Intubation | Neurological Failure
-
Cliniques universitaires Saint-Luc- Université...UnknownCardio-Respiratory DistressBelgium
-
Groupe Hospitalier Pitie-SalpetriereCompletedPneumonia | Cardiopulmonary Bypass | Cardio/Pulm: Respiratory Failure
-
Erasmus Medical CenterRecruitingExtracorporeal Membrane Oxygenation | Cardio/Pulm: Heart FailureNetherlands
-
Assiut UniversityNot yet recruitingCardio Respiratory Arrest
-
Nantes University HospitalCompletedPrehospital Cardio-Respiratory Arrests | Spontaneous Circulatory Activity RecoveryFrance
-
Assiut UniversityNot yet recruitingHeart Diseases | Heart Valve Diseases | Acute Kidney Injury | Cardiopulmonary Arrest With Successful Resuscitation | Cardio-Renal Syndrome | Cardiac Disease | Coronary Artery Bypass Surgery | Cardiothoracic Surgery | Cardio-pulmonary Bypass | Cardiopulmonary Disease | Cardio Respiratory Arrest | Heart Shock | Acute...
-
University of LjubljanaScience and Research Centre KoperCompletedPhysical Fitness | Physical Examination | Aerobic Capacity | Cardio Respiratory Fitness | Combat PreparednessSlovenia
-
University Hospital RegensburgUniversity of MagdeburgTerminated
Clinical Trials on Adapted physical activity
-
Assistance Publique Hopitaux De MarseilleNot yet recruiting
-
University Hospital, CaenNot yet recruitingChronic Pain | Multiple Myeloma | Adapted Physical Activity
-
Central Hospital, Nancy, FranceRecruiting
-
WepromRecruitingLymphoma | Myeloma | Autologous TransplantFrance
-
Centre Hospitalier Universitaire de NiceCompleted
-
Support and Education Technic CentreCompletedHeart Failure | Cardiovasculars Risk FactorsFrance, Cameroon
-
University of LausanneCompletedPostural ControlSwitzerland
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Mon Stade Sports Medicine CentreLaboratory MOVE, Faculty of Sport Sciences, University of Poitiers, France; Public Health Foundation of MGEN, France and other collaboratorsRecruitingPhysical Activity | Life Style, Healthy | Adherence, Patient | Life Style | Cost-Benefit Analysis | Behavior and Behavior Mechanisms | Exercise Therapy | Adapted Physical Activity | Lifestyle, Sedentary | PrescriptionsFrance
-
Centre Hospitalier Universitaire de NiceCompleted